News & Announcements

Michael Aiello and Steve Newborn Named NLJ M&A and Antitrust “Trailblazers” in 2015

Corporate Department Chairman Michael Aiello and Head of the Antitrust/Competition practice Steven Newborn have been recognized as Mergers & Acquisitions and Antitrust “Trailblazers,” respectively, by The National Law Journal

In a special supplement to NLJ published today, Mr. Aiello and Mr. Newborn are recognized among an elite group of about 50 groundbreaking attorneys who have “moved the needle” in M&A and antitrust law.

Mr. Aiello is highlighted for his roles in a number of pivotal M&A deals stretching back more than a decade, including representing Omnicare in its hostile takeover of NCS Healthcare, Sanofi in its acquisition of Genzyme, and Health Management Associates in its sale to Community Health Systems.

Mr. Newborn was the FTC’s primary legal contributor to the 1992 Federal Merger Guidelines, which have been referred to as “the best thing ever written on merger analysis.”  In addition, he tried the first successful 7(A)G(2) case, which relates to the interplay between antitrust laws and bankruptcy laws. Today, he represents approximately 20 of the Fortune 100 companies for all their antitrust needs.